HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Analyst report and media coverage of potential merger of Colgate-Palmolive and Gillette results in Colgate 2-7/16 stock increase to 57 - a 4.5% jump - on June 7. Gillette stock rose 1/8 to 34-7/8. Following an earlier report from Goldman, Sachs VP Amy Chasen speculating on the merger and an initial Wall Street Journal article June 2, Colgate stock rose 1-1/16 to 54-1/2 and Gillette inched up 13/16 to 35-9/16. Although the probability of a Colgate/Gillette union is unlikely, Gillette's strong brands and market exposure could make the company an attractive buy (1"The Rose Sheet" Jan. 31, p. 11). If Colgate places a bid for Gillette, it potentially would not be the first personal care products company to show an interest; Procter & Gamble is understood to have sent a proposition to Gillette early this year

You may also be interested in...

Gillette Market Exposure, Strong Brands Could Put Company In Play

Gillette's market vulnerability and the recent heavy merger activity among pharmaceutical diversifieds may make the company a potential acquisition target.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts